Gliclazida Mylan

Gliclazide Mylan is a medication used to manage type 2 diabetes by helping to control blood sugar levels. This oral antidiabetic agent is part of the sulfonylurea class and is manufactured by Viatris Limited.

Gliclazide Mylan is primarily used to treat type 2 diabetes mellitus. It works by stimulating the pancreas to produce more insulin, which helps to lower blood sugar levels. This medication is often prescribed for individuals who have not achieved adequate blood sugar control through diet and exercise alone. Gliclazide Mylan is not suitable for treating type 1 diabetes or diabetic ketoacidosis.

Common effects of Gliclazide Mylan may include hypoglycemia, or low blood sugar, which can cause symptoms such as sweating, dizziness, and confusion. Other potential effects include nausea, vomiting, and stomach pain. It is important to monitor blood sugar levels regularly while taking this medication.

Gliclazide Mylan should be used with caution in individuals with liver or kidney disease. It is important to follow the prescribed dosage and not to skip meals while taking this medication. Regular blood sugar monitoring is essential to avoid hypoglycemia. Always consult a healthcare provider before starting or stopping any medication.

Gliclazide Mylan may interact with other medications, including certain antibiotics, antifungal agents, and other diabetes medications. Alcohol can increase the risk of hypoglycemia and should be avoided. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.